Axon Enterprise
AXON
#541
Rank
NZ$75.18 B
Marketcap
NZ$952.81
Share price
0.06%
Change (1 day)
-13.42%
Change (1 year)

Market capitalization of Axon Enterprise (AXON)

Market cap: NZ$75.18 Billion

As of December 2025 Axon Enterprise has a market cap of NZ$75.18 Billion. This makes Axon Enterprise the world's 541th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Axon Enterprise from 2001 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$75.18 B-8.99%
2024NZ$82.61 B169.88%
2023NZ$30.60 B64.58%
2022NZ$18.59 B18.18%
2021NZ$15.73 B45.33%
2020NZ$10.82 B67.27%
2019NZ$6.47 B68.77%
2018NZ$3.83 B94.28%
2017NZ$1.97 B7.91%
2016NZ$1.82 B34.88%
2015NZ$1.35 B-24.28%
2014NZ$1.79 B75.8%
2013NZ$1.01 B77.67%
2012NZ$0.57 B57.28%
2011NZ$0.36 B-4.42%
2010NZ$0.38 B1.84%
2009NZ$0.37 B-33.28%
2008NZ$0.56 B-52.53%
2007NZ$1.18 B77.65%
2006NZ$0.66 B5.57%
2005NZ$0.63 B-76.69%
2004NZ$2.70 B405.34%
2003NZ$0.53 B2359.66%
2002NZ$21.76 M-76.47%
2001NZ$92.51 M

End of Day market cap according to different sources

On Dec 7th, 2025 the market cap of Axon Enterprise was reported to be:

NZ$75.18 Billion
by Nasdaq info icon info icon
NZ$75.18 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
XBiotech
XBIT
NZ$0.13 B-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.79 B-98.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.28 B-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$20.65 B-72.53%๐Ÿ‡บ๐Ÿ‡ธ USA